A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily Plus Insulin Aspart for the Remaining Meals Versus Insulin Detemir Once or Twice Daily Plus Meal Time Insulin Aspart in Children and Adolescents With Type 1 Diabetes Mellitus
Clinical trial NCT01835431 · COMPLETED
Trial details
- NCT number
- NCT01835431
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-17
- Primary completion
- 2014-11-07
- Enrollment
- 362
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.